Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill R Schofield

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Case Reports in Internal Medicine|April 19, 2021
Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year OnJill R Schofield
Immunologic Research|January 25, 2017
Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndromeJill R Schofield
European Neurology|March 20, 2019
How We Treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin TherapyJill R Schofield, Kamal R Chemali
American Journal of Therapeutics|May 22, 2018
Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 PatientsJill R Schofield, Kamal R Chemali
The American Journal of the Medical Sciences|May 26, 2019
Recognition and Management of Medication Excipient Reactivity in Patients With Mast Cell Activation SyndromeJill R Schofield, Lawrence B Afrin
Immunologic Research|August 12, 2024
Elevated total serum IgM predicts the presence of antiphospholipid antibodies in dysautonomia patientsJill R Schofield, Jill Brook, Denise Calaprice-Whitty
Lupus|January 6, 2021
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patientsJill R Schofield, Hannah N Hughes, Marius Birlea, et al.
American Journal of Ophthalmology Case Reports|April 24, 2019
Deep capillary retinal ischemia and high-titer prothrombin-associated antiphospholipid antibodies: A case series of three patientsJill R Schofield, Alan G Palestine, Victoria Pelak, et al.
The American Journal of the Medical Sciences|July 17, 2025
Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndromeLawrence B Afrin, Leonard B Weinstock, Tania T Dempsey, et al.
Brain, Behavior, & Immunity - Health|July 21, 2025
Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndromeLeonard B Weinstock, Lawrence B Afrin, Angela M Reiersen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Case Reports in Internal Medicine|April 19, 2021
Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year OnJill R Schofield
Immunologic Research|January 25, 2017
Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndromeJill R Schofield
European Neurology|March 20, 2019
How We Treat Autoimmune Small Fiber Polyneuropathy with Immunoglobulin TherapyJill R Schofield, Kamal R Chemali
American Journal of Therapeutics|May 22, 2018
Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 PatientsJill R Schofield, Kamal R Chemali
The American Journal of the Medical Sciences|May 26, 2019
Recognition and Management of Medication Excipient Reactivity in Patients With Mast Cell Activation SyndromeJill R Schofield, Lawrence B Afrin
Immunologic Research|August 12, 2024
Elevated total serum IgM predicts the presence of antiphospholipid antibodies in dysautonomia patientsJill R Schofield, Jill Brook, Denise Calaprice-Whitty
Lupus|January 6, 2021
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patientsJill R Schofield, Hannah N Hughes, Marius Birlea, et al.
American Journal of Ophthalmology Case Reports|April 24, 2019
Deep capillary retinal ischemia and high-titer prothrombin-associated antiphospholipid antibodies: A case series of three patientsJill R Schofield, Alan G Palestine, Victoria Pelak, et al.
The American Journal of the Medical Sciences|July 17, 2025
Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndromeLawrence B Afrin, Leonard B Weinstock, Tania T Dempsey, et al.
Brain, Behavior, & Immunity - Health|July 21, 2025
Prevalence and treatment response of neuropsychiatric disorders in mast cell activation syndromeLeonard B Weinstock, Lawrence B Afrin, Angela M Reiersen, et al.
Pageof 2